NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN)
1.1300
-0.0500 (-4.24%)
NeuroSense Therapeutics Ltd. is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases, particularly those that affect human cognition and function, such as Alzheimer's and Parkinson's diseases
The company leverages advanced research and proprietary technologies to discover and create novel treatment options aimed at addressing the unmet medical needs of patients suffering from these debilitating conditions. Through its comprehensive approach, NeuroSense aims to improve the quality of life for individuals affected by neurodegenerative disorders while advancing the field of neuroscience.
Frequently Asked Questions
Is NeuroSense Therapeutics Ltd. - Ordinary Shares publicly traded?
Yes, NeuroSense Therapeutics Ltd. - Ordinary Shares is publicly traded.
What exchange does NeuroSense Therapeutics Ltd. - Ordinary Shares trade on?
NeuroSense Therapeutics Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroSense Therapeutics Ltd. - Ordinary Shares?
The ticker symbol for NeuroSense Therapeutics Ltd. - Ordinary Shares is NRSN on the Nasdaq Stock Market
What is the current price of NeuroSense Therapeutics Ltd. - Ordinary Shares?
The current price of NeuroSense Therapeutics Ltd. - Ordinary Shares is 1.130
When was NeuroSense Therapeutics Ltd. - Ordinary Shares last traded?
The last trade of NeuroSense Therapeutics Ltd. - Ordinary Shares was at 1:11 pm EDT on March 18th, 2025